Skip to content
Comparisons7 min read5 August 2026

MK-677 vs Ipamorelin: Oral vs Injectable GH Secretagogues

Comparing MK-677 (oral, long-acting GH secretagogue) with Ipamorelin (injectable, selective GH secretagogue) — two fundamentally different approaches to growth hormone research in test subjects.

Historical research article — verify before use: Some older examples, including amounts, routes, diluents and storage windows, have not been individually rechecked against current primary sources and may not apply to any human or supplier vial. Always check the exact product's formulation, primary sources and current licensed instructions before interpreting preparation or dosing information.

Overview: Oral Convenience vs Injectable Precision

MK-677 (Ibutamoren) and Ipamorelin both stimulate growth hormone release through the ghrelin receptor, but their delivery methods and pharmacokinetics are fundamentally different. MK-677 is an orally active, non-peptide GH secretagogue with a 24-hour duration of action — producing sustained GH and IGF-1 elevation. Ipamorelin is an injectable peptide with a short half-life that produces discrete, natural-pattern GH pulses. This difference in GH release pattern (sustained vs pulsatile) has significant implications for research outcomes in test subjects. For research purposes only.

Head-to-Head Comparison Table

Administration: MK-677 = Oral (capsule/liquid) | Ipamorelin = Subcutaneous injection Half-life: MK-677 = 24 hours | Ipamorelin = ~2 hours GH release pattern: MK-677 = Sustained 24hr elevation | Ipamorelin = Discrete pulses IGF-1 elevation: MK-677 = Significant and sustained | Ipamorelin = Moderate and transient Dose: MK-677 = 10-25 mg daily (oral) | Ipamorelin = 100-250 mcg 1-3x daily (injection) Hunger increase: MK-677 = Significant | Ipamorelin = None Water retention: MK-677 = Common | Ipamorelin = Rare Blood glucose impact: MK-677 = May increase | Ipamorelin = Minimal Sleep improvement: MK-677 = Strong | Ipamorelin = Moderate Cycle length: MK-677 = 8-12 weeks | Ipamorelin = 12-16 weeks Convenience: MK-677 = High (no injections) | Ipamorelin = Lower (daily injections) Selectivity: MK-677 = Low | Ipamorelin = Very high

Which to Choose for Research

Choose MK-677 when: Oral administration is required for the protocol, sustained 24-hour GH/IGF-1 elevation is the research objective, injection compliance is a concern, or the study investigates long-acting ghrelin receptor agonism in test subjects. Choose Ipamorelin when: Natural pulsatile GH release is preferred, selective GH stimulation without hunger/water retention is required, the protocol involves stacking with CJC-1295, or clean pharmacological data without confounding side effects is needed in test subjects. Ipamorelin produces more physiological GH release patterns, while MK-677 offers convenience and sustained elevation. Many researchers consider Ipamorelin superior for quality of GH stimulation despite the injection requirement. For research purposes only.
Related Topics
MK-677 vs ipamorelinibutamoren comparisonoral vs injectable GHMK-677 side effectsGH secretagogue oral

Check the concentration arithmetic

Use the calculator only after verifying a vial's content and actual final liquid volume. It is not a dosing instruction.

Open Calculator →

Disclaimer: This content is for educational and research purposes only. Supplier research products are not medicines approved for human use. Always consult relevant regulations and current product information.